ACB.TO - Aurora Cannabis Inc.

Toronto - Toronto Delayed Price. Currency in CAD
6.67
-0.16 (-2.34%)
At close: 4:18PM EDT
Stock chart is not supported by your current browser
Previous Close6.83
Open6.77
Bid6.66 x 0
Ask6.67 x 0
Day's Range6.55 - 6.78
52 Week Range6.21 - 16.24
Volume6,880,894
Avg. Volume4,213,303
Market Cap6.771B
Beta (3Y Monthly)2.76
PE Ratio (TTM)N/A
EPS (TTM)-0.29
Earnings DateNov 11, 2019 - Nov 15, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.73
  • U.S. pot analyst: 'Don't smoke the Kool-Aid,' but Hexo and Acreage are buys
    Yahoo Finance Canada

    U.S. pot analyst: 'Don't smoke the Kool-Aid,' but Hexo and Acreage are buys

    The future of cannabis is looking less profitable, according to an analyst who initiated coverage on five Canadian pot producers and two U.S. multi-state operators on Friday.

  • 1 Monster Weed Stock to Buy Instead of Aurora (TSX:ACB) (USA)
    The Motley Fool

    1 Monster Weed Stock to Buy Instead of Aurora (TSX:ACB) (USA)

    Looking to buy stock in the marijuana industry? Find out what stock is a better choice than the marijuana giant Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB)

  • Aurora (TSX:ACB) Just Dumped This Weed Stock: Should You Do the Same?
    The Motley Fool

    Aurora (TSX:ACB) Just Dumped This Weed Stock: Should You Do the Same?

    It seems that partnerships in the cannabis space are not meant to last. Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB), the key partner of The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) before and after its IPO, just dumped the organic cannabis producer.

  • CNW Group

    Aurora Cannabis Announces Date of Annual General Meeting

    TSX: ACB | NYSE: ACB EDMONTON , Sept. 20, 2019 /CNW/ - Aurora Cannabis Inc. (the " Company " or " Aurora ") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, ...

  • Cannabis Roundup: HEXO, CRON, CURA, and ACB
    Market Realist

    Cannabis Roundup: HEXO, CRON, CURA, and ACB

    Bad news on the trade war front appears to have led to a fall in the broader US equity markets today. Cannabis ETFs were also trading in the red.

  • Mayor to Regulate Cannabis Stores in Chicago
    Market Realist

    Mayor to Regulate Cannabis Stores in Chicago

    Chicago mayor Lori Lightfoot has introduced an ordinance regulating cannabis stores, keeping them away from the city's central business district.

  • Contrarian Investors: Is Aurora Cannabis (TSX:ACB) Stock a Buy?
    The Motley Fool

    Contrarian Investors: Is Aurora Cannabis (TSX:ACB) Stock a Buy?

    Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) is down 50% in the past six months. Is this pot stock now oversold?

  • 3 Beaten-Down Marijuana Stocks: Great Time to Buy?
    The Motley Fool

    3 Beaten-Down Marijuana Stocks: Great Time to Buy?

    Canopy Growth Corp (TSX:WEED)(NYSE:CGC), Cronos Group Inc (TSX:CRON)(NASDAQ:CRON), and Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) could be excellent buying opportunities.

  • Cannabis Samples Didn’t Pass Tests in Nevada
    Market Realist

    Cannabis Samples Didn’t Pass Tests in Nevada

    The Nevada Department of Taxation announced that four cannabis products sold between May 28 and July 10 failed the secondary microbial test.

  • Marijuana Legalization: O’Rourke Blazes His 2020 Campaign
    Market Realist

    Marijuana Legalization: O’Rourke Blazes His 2020 Campaign

    Democratic presidential candidate Beto O’Rourke is known for voicing his opinion on federal marijuana legalization. He supports marijuana legalization.

  • Cannabis Sell-off: Aurora Cannabis (TSX:ACB) Leads Decline in Cannabis Stocks
    The Motley Fool

    Cannabis Sell-off: Aurora Cannabis (TSX:ACB) Leads Decline in Cannabis Stocks

    How long will investors hold onto Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) and peer cannabis stocks? The cannabis market has failed to recover despite falling significantly in the last 12-months.

  • Cannabis 2.0: Aurora Cannabis Gears Up for Edibles Market
    Market Realist

    Cannabis 2.0: Aurora Cannabis Gears Up for Edibles Market

    Cannabis 2.0 legalization will take place in Canada next month. Cannabis players are gearing up to expand in the edibles market.

  • CBD Products: McConnell Wants FDA to Ease Regs
    Market Realist

    CBD Products: McConnell Wants FDA to Ease Regs

    Earlier this week, Senator Mitch McConnell submitted a proposal that would require the FDA to set a policy for the sale of hemp CBD products.

  • The Cannabis Market Is Looking Up, Even If Cannabis Stocks Aren’t
    Bloomberg

    The Cannabis Market Is Looking Up, Even If Cannabis Stocks Aren’t

    (Bloomberg Opinion) -- Almost exactly a year ago, a small Canadian cannabis company was generating a lot of buzz (sorry, couldn’t resist the pun). Despite trifling quarterly revenue of $9.7 million, Tilray Inc.’s market capitalization got so high (sorry again, I’ll stop) that it briefly eclipsed that of major companies people have actually heard of, such as American Airlines Group Inc.The boom quickly faded — not surprising, given how senseless it looked even in the moment — and Tilray’s stock has continued to decline. And the cannabis sector has also stumbled recently.But this dampened enthusiasm for marijuana stocks does not necessarily reflect fading prospects for the marijuana market, which still has promise. Instead, it is related to short-term challenges associated with a bumpy rollout of legal marijuana in Canada, which are making it hard for winners to quickly emerge.In October 2018, Canada became only the second country to legalize recreational marijuana. But it’s still not particularly easy for Canadian consumers to get their hands on cannabis, as the pace of dispensary openings has been slow.In a research note, Vivien Azer of Cowen & Co. offered this example to demonstrate how sparse dispensaries are, on a per capita basis, in Ontario, the country’s most populous province:Kenneth Shea, a Bloomberg Intelligence analyst, notes that even within the small ecosystem of stores, it’s been tough in early days to match supply with demand, with dispensaries sometimes sold out of higher-quality strains.Meanwhile, average prices for legal cannabis remain well above prices on the illegal market. If the legal product is still inconvenient to buy, and if the illegal product is cheaper, then it follows that dispensary sales of cannabis haven’t exactly soared yet.In this fast-evolving, Wild West of a market, some industry heavyweights have ended up disappointing investors with their recent sales or profitability figures. Aurora Cannabis Inc., for one, had said in May it was on track to achieve growth in adjusted earnings before interest, taxes, depreciation and amortization in the fourth quarter. When it reported results last week, it said it had failed to meet this target, citing “challenges at the retail level” that were “beyond its control.”That doesn’t mean there aren’t realistic paths for the industry’s leading companies to earn more revenue as they bolster their capacity and as the forthcoming addition of more Canadian retail locations gives them a chance to court more customers. Plus, some of the biggest opportunity in Canada is yet to come: In the first year of legalization, the country allowed sales of only certain cannabis products, including smokeable flower and oils. Edibles and beverages are to be phased in later this year, potentially drawing interest from a wider swath of consumers who aren’t interested in smoking but are curious about cannabis.Looking beyond Canada, forecasts suggest medical and recreational markets will continue to open up worldwide, providing ample opportunity for long-term growth if these companies can ramp up their supply quickly and build compelling brands.So, a year after Tilray’s wild ride, investors seem to be getting more cautious about cannabis stocks. It’s hard to know which companies will eventually prosper — and it’s risky to try to make a quick investing buck from it. The outlook for the industry as a whole, however, remains plenty upbeat.To contact the author of this story: Sarah Halzack at shalzack@bloomberg.netTo contact the editor responsible for this story: Michael Newman at mnewman43@bloomberg.netThis column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Sarah Halzack is a Bloomberg Opinion columnist covering the consumer and retail industries. She was previously a national retail reporter for the Washington Post.For more articles like this, please visit us at bloomberg.com/opinion©2019 Bloomberg L.P.

  • Baystreet

    Cannabis is The Fastest Growing Catalyst for Major Retailers

    Cannabis has become the hottest investment story of the year with no shortage of bullish analysts. For ...

  • Forget Weed Stocks: This Tech Stock Is Set to Explode Soon
    The Motley Fool

    Forget Weed Stocks: This Tech Stock Is Set to Explode Soon

    Aurora Cannabis Inc (TSE:ACB)(NYSE:ACB) highlights the weed industry’s performance, but tech stock Lightspeed POS Inc (TSE:LSPD) is set to leave Aurora behind.

  • Why You Should Buy This Stock on Analyst Downgrades
    The Motley Fool

    Why You Should Buy This Stock on Analyst Downgrades

    Sometimes, an analyst downgrade is actually a buying opportunity in disguise like the recent sell rating of Aurora Cannabis (TSX:ACB)(NYSE:ACB).

  • 1 Cannabis Stock Is All You Need to Get Wealthy
    The Motley Fool

    1 Cannabis Stock Is All You Need to Get Wealthy

    You shouldn’t be frustrated with how the cannabis industry is behaving in the present. Things are beginning to settle down. If you want to get wealthy, pick Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB).